Stockreport

Navidea Biopharmaceuticals Announces Preclinical Therapeutic Research Collaboration with IMV Inc. to Explore the Potential Combinatory Effect with Their Platform-Based Immunotherapies

Navidea Biopharmaceuticals, Inc.  (NAVB) 
NASDAQ:AMEX Investor Relations: ir.navidea.com
PDF DUBLIN, Ohio & DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB), a company focused on the development of precision imm [Read more]